CSIMarket Company Name, Ticker, Customers, else..


Oncocyte Corporation  (OCX)
Other Ticker:  
 

Oncocyte Corporation

OCX's Fundamental analysis



Oncocyte's sales fell by -96.31 % in I. Quarter 2024 from the same quarter a year ago. Ranking at No. 3284

In Vitro & In Vivo Diagnostic Substances industry recorded growth of revenues by 0.55 %

Oncocyte net loss decreased from $-64 millions, to $0 millions in I. Quarter 2024,

• More on OCX's Growth


Oncocyte
realized a net loss in trailing twelve months.

Oncocyte realized cash reduction of $ -1.4 per share in trailing twelve-month period.
In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 18.77.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 8.3.


• More on OCX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 0.95
 Tangible Book Value (Per Share $) -5.44

Oncocyte
realized net loss in trailing twelve months.

Oncocyte realized cash outflow of $ -1.4per share in trailing twelve-month period.
In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 18.77.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 8.3.

Oncocyte Price to Book Ratio is at 2.18 lower than Industry Avg. of 413.05. and higher than S&P 500 Avg. of 0

• More on OCX's Valuation

•  Market Capitalization (Millions $) 25
•  Shares Outstanding (Millions) 8
•  Employees -
•  Revenues (TTM) (Millions $) 1
•  Net Income (TTM) (Millions $) -13
•  Cash Flow (TTM) (Millions $) -12
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 0.95
•  Tangible Book Value (Per Share $) -5.44

•  Market Capitalization (Millions $) 25
•  Shares Outstanding (Millions) 8
•  Employees -
•  Revenues (TTM) (Millions $) 1
•  Net Income (TTM) (Millions $) -13
•  Cash Flow (TTM) (Millions $) -12
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 0.78
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.02
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com